TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
SPRB

Spruce Biosciences, Inc.

Healthcare · Biotechnology

47.50$ -2.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow SPRB
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – -2,122.4% -329.8% -1,139.6% –
– – – – 3.8% 0.7% 0.9% –
– – – – 184.9% 45.8% 108.9% –
– – – – 186.9% – – –
– – – – 57.6% 102.6% -174.5% –
– – – – 0.4% 0.1% 0.0% –
– – – – 1,206.3% 552.8% – –
– – – – – 1.7% – –
– – – – -2.0% -3.1% 1.3% –
– – – – 0.0% -16.1% -33.0% –
– – – – -12.3% 487.1% -33.0% –
– – – – -918.8% 710.1% -1,172.6% –
– – – – -2,122.8% -329.9% -1,139.6% –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?